These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Drug-related myopathies of which the clinician should be aware. Valiyil R; Christopher-Stine L Curr Rheumatol Rep; 2010 Jun; 12(3):213-20. PubMed ID: 20425521 [TBL] [Abstract][Full Text] [Related]
13. Corticosteroid-induced myopathy of the respiratory muscles. van Balkom RH; van der Heijden HF; van Herwaarden CL; Dekhuijzen PN Neth J Med; 1994 Sep; 45(3):114-22. PubMed ID: 7969664 [TBL] [Abstract][Full Text] [Related]
15. Adverse reactions and interactions with beta-adrenoceptor blocking drugs. Lewis RV; McDevitt DG Med Toxicol; 1986; 1(5):343-61. PubMed ID: 2878346 [TBL] [Abstract][Full Text] [Related]
16. Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives. Hedenmalm K; Granberg AG; Dahl ML Eur J Clin Pharmacol; 2015 Jan; 71(1):117-24. PubMed ID: 25367069 [TBL] [Abstract][Full Text] [Related]
18. Acute hypokalaemic myopathy with lipid storage during chlortalidone therapy. Lovaste MG; Aldovini D; Dal Ri E; Ferrari G Acta Neurol (Napoli); 1984 Dec; 6(6):424-31. PubMed ID: 6524467 [No Abstract] [Full Text] [Related]
19. A rat model of spontaneous myopathy and malignant hyperthermia. Gonzalez LE; Meléndez-Vásquez CV; Gregson NA; File SE Am J Pathol; 1998 Apr; 152(4):1099-103. PubMed ID: 9546371 [TBL] [Abstract][Full Text] [Related]
20. [Direct mechanism of action in toxic myopathies]. Khelfi A; Azzouz M; Abtroun R; Reggabi M; Alamir B Ann Pharm Fr; 2017 Sep; 75(5):323-343. PubMed ID: 28526123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]